Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 86
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
23
Q2
26
Q3
16
Q4
13
WoS (JCR)
Q1
10
Q2
16
Q3
28
Q4
23
TR Index
16
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
3
Üst %10 makale
10
Ort. yüzdelik
59.9%
Üst %1 payı
4.0%
Üst %10 payı
13.3%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Adult-onset desmin myopathy in a patient with multiple sclerosis YÖKSİS SJR Q4 JCR Q4 OpenAlex 66.9%
- 2025 Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 96.9%
- 2025 Nivolumab- and ipilimumab-induced myositis, myasthenia gravis, and myocarditis in a patient with metastatic melanoma YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 96.3%
- 2025 Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single‐Center Experience YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 97.0%
- 2025 Random X chromosome inactivation in female Charcot-Marie-Tooth disease type X1: insights from sural nerve biopsy analysis YÖKSİS SJR Q2 JCR Q3 OpenAlex 15.3%
- 2024 Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis YÖKSİS SJR Q3 JCR Q3 OpenAlex 57.3%
- 2024 Differentiating recurrent Guillain–Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review YÖKSİS SJR Q2 JCR Q3 OpenAlex 87.2%
- 2024 Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.9%
- 2023 Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.4%
- 2023 The evaluation of small fibers in multiple sclerosis YÖKSİS SJR Q1 JCR Q2 OpenAlex 61.9%
- 2023 Nusinersen for adults with spinal muscular atrophy YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.8%
- 2022 Identifying a Cut-off Point for Timed Up and Go Test in Neuromuscular Diseases YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 27.1%
- 2022 Two distinct skeletal muscle microRNA signatures revealing the complex mechanism of sporadic ALS YÖKSİS SJR Q2 JCR Q3 OpenAlex 59.5%
- 2022 Multimodal assessment of intensive care unit-acquired weakness in severe stroke patients YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.3%
- 2022 The functional and structural evaluation of small fibers in asymptomatic carriers of p.Val50Met (Val30Met) mutation YÖKSİS SJR Q1 JCR Q3 OpenAlex 69.2%
- 2022 Comprehensive evaluation of velopharyngeal function in myasthenia gravis patients YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.6%
- 2022 Treatment for Spinal Muscular Atrophy Using Onasemnogene Abeparvovec YÖKSİS SJR Q3 OpenAlex 28.1%
- 2021 Reliability and Validity of Turkish Myasthenia Gravis-Activities of Daily Living Scale YÖKSİS SJR Q2 JCR Q3 OpenAlex 59.4%
- 2021 One Disease with two Faces: Semidominant Inheritance of a Novel HTRA1 Mutation in a Consanguineous Family YÖKSİS SJR Q1 JCR Q3 OpenAlex 67.6%
- 2021 Biologia Futura: the importance of 3D organoids\u2014a new approach for research on neurological and rare diseases YÖKSİS SJR Q2 JCR Q4 OpenAlex 38.1%